IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Iron Triangle Partners LP

Q4 2022 Holdings

Filed 2023-02-14 | 26 holdings | $557.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Icon PLC(ICLR)SHSG4705A100$43.7M225,0007.8%
Charles RIV Labs Intl Inc(CRL)COM159864107$43.6M200,0007.8%
Universal Hlth Svcs Inc(UHS)CL B913903100$42.3M300,0007.6%
Cooper COS IncCOM NEW216648402$40.7M123,0007.3%
Surgery Partners Inc(SGRY)COM86881A100$35.7M1,280,0006.4%
Gilead Sciences Inc(GILD)COM375558103$32.1M373,5695.8%
Sanofi(SNY)SPONSORED ADR80105N105$31.5M650,0005.6%
Repligen Corp(RGEN)COM759916109$30.1M178,0005.4%
Boston Scientific Corp(BSX)COM101137107$27.8M600,0005.0%
Establishment Labs Hldgs Inc(ESTA)COMG31249108$26.7M407,0744.8%
Inspire MED SYS Inc(INSP)COM457730109$20.2M80,0003.6%
United Therapeutics Corp del(UTHR)COM91307C102$19.9M71,5763.6%
Cigna Corp New(CI)COM125523100$19.9M60,0003.6%
Intuitive Surgical Inc(ISRG)COM NEW46120E602$18.6M70,0003.3%
Acadia Healthcare Company in(ACHC)COM00404A109$16.5M200,0003.0%
Sarepta Therapeutics Inc(SRPT)COM803607100$14.0M107,7492.5%
Pacific Biosciences Calif in(PACB)COM69404D108$13.9M1,700,0002.5%
Dexcom Inc(DXCM)COM252131107$13.6M120,0802.4%
Inari MED Inc(NARIUSD)COM45332Y109$12.1M190,0002.2%
Neurocrine Biosciences Inc(NBIX)COM64125C109$12.0M100,0892.1%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$9.4M370,2941.7%
Amylyx Pharmaceuticals Inc(AMLX)COM03237H101$8.9M240,2401.6%
Prometheus Biosciences IncCOM74349U108$8.3M75,0001.5%
908 Devices Inc(MASS)COM65443P102$6.7M874,7311.2%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$6.6M1,926,7821.2%
Stereotaxis Inc(STXS)COM NEW85916J409$3.5M1,671,1090.6%